The evolution of brachytherapy treatment planning

Area of Science:

• Medical Physics
• Radiation Oncology
• Brachytherapy

Background:

• Brachytherapy is an established cancer treatment that has evolved with technology.
• Current treatment planning relies on the AAPM TG-43 formalism, which has limitations for accurate patient dose calculation.
• Recent advancements include improved dose distribution acquisition and the development of sophisticated dose calculation algorithms.

Purpose of the Study:

• To provide insight into the ongoing advancements in brachytherapy treatment planning.
• To highlight the limitations of current formalisms and the development of new dose calculation methods.
• To discuss the integration of new technologies and professional society initiatives in radiation oncology.

Main Methods:

• Review of technological advancements in brachytherapy treatment planning.
• Discussion of limitations of the AAPM TG-43 formalism.
• Overview of emerging dose-calculation algorithms (Monte Carlo, collapsed cone, Boltzmann transport equation).
• Exploration of integrated planning system features including heterogeneities, scatter, radiobiology, and image guidance.

Main Results:

• The AAPM TG-43 formalism has clinically relevant limitations for patient dose calculation.
• Advanced dose-calculation algorithms are under development to overcome these limitations.
• Future brachytherapy planning systems will incorporate material heterogeneities, scatter, radiobiology, and image guidance.
• Professional societies are coordinating the clinical integration of these advancements.

Conclusions:

• Brachytherapy treatment planning is advancing significantly beyond current formalisms.
• New dose calculation methods and integrated systems will enhance treatment accuracy and personalization.
• Collaborative efforts by professional societies are crucial for the successful clinical adoption of these innovations.